FDA approves new mRNA-based flu vaccine
The U.S. Food and Drug Administration has approved a new mRNA-based seasonal flu vaccine for people 50 and older, Moderna said this week.
Original Source
Read the full article at Upi →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.